Sun Pharma Advanced Research Company (SPARC) slipped 5.09% to Rs 205.10 after the company reported net loss of Rs 107.28 crore in Q2 FY25 as compared with net loss of Rs 86.08 crore in Q2 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
